V
Generic Name: selegiline
Pill imprint V has been identified as Zelapar 1.25 mg.
Zelapar is used in the treatment of parkinson's disease; depression; adhd and belongs to the drug classes dopaminergic antiparkinsonism agents, monoamine oxidase inhibitors. Risk cannot be ruled out during pregnancy.
Zelapar 1.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Zelapar Images
- Generic Name:
- selegiline
- Imprint:
-
V
- Strength:
- 1.25 mg
- Color:
- Yellow
- Size:
- 12.00 mm
- Availability:
- Prescription only
- Inactive Ingredients:
- gelatin
mannitol
glycerin
aspartame
citric acid monohydrate
ferric oxide yellow
- Drug Class:
- Dopaminergic antiparkinsonism agents
Monoamine oxidase inhibitors - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Valeant Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00187-0453
Advertisement
More Zelapar resources
- Zelapar
- Zelapar Orally Disintegrating Tablets (Wolters Kluwer)
- Zelapar (Cerner Multum)
- Zelapar (Micromedex) - Includes Dosage Information
- Zelapar (FDA)
Search Again
